Clinical trials: Visual Fields
Visual Field Defect, Peripheral, Stroke
Improving Visual Field Deficits With Noninvasive Brain Stimulation
This is a randomized, pilot interventional study in participants with visual field deficit (VFD) caused by cortical lesion. Damage to the primary visual cortex (V1) causes a contra-lesional, homonymous loss of conscious vision…
- Conditions
- Visual Field Defect, Peripheral, Stroke, Visual Impairment, Hemianopsia
- Trial name
- NCT05085210
- Testing
- transcranial random noise stimulation (tRNS), Computer Based Visual Training, Virtual Reality Based Visual Training
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Beth Israel Deaconess Medical Center
Glaucoma, Open-Angle
Evaluating Home Testing Devices for the Management of Glaucoma
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with…
- Trial name
- NCT05325996
- Testing
- Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer
- Where
- United States
- Volunteers
- 53 people
- Sponsor
- Wills Eye
Visual Field Defects, Visual Field Loss
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
The goal of this clinical trial is to learn if visual restoration therapy (VRT) (a type of treatment that aims to improve vision) works to the visual rehabilitation of patients with visual field defects.
- Trial name
- NCT06914505
- Testing
- visual restoration therapy
- Volunteers
- 58 people
- Sponsor
- Xuanwu Hospital, Beijing
Glaucoma
World Sight Foundation Field Machine (WSFFM) Pilot
The current situation outside of large cities in lower-income countries, as described above, is suboptimal for the diagnosis of glaucoma.
- Trial name
- WSFFM (NCT07674069)
- Testing
- World Sight Foundation Field Machine, Comparator
- Where
- United Kingdom
- Volunteers
- 100 people
- Sponsor
- Buckinghamshire Healthcare NHS Trust
Glaucoma, Eye Disorders
Effectiveness of a Large Language Model-Based Educational Tool on Visual Field Test Reliability in Glaucoma Patients
The purpose of this study is to evaluate whether a large language model (LLM)-based audiovisual educational tool improves the test time and reliability of standard automated perimetry (SAP) using the SITA Standard 24-2 protocol…
- Conditions
- Glaucoma, Eye Disorders, Visual Fields, Visual Field Tests
- Trial name
- NCT07327242
- Testing
- LLM-based Education
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Stanford University
Retinitis Pigmentosa
Trial of Oral Valproic Acid for Retinitis Pigmentosa
The objectives of this study are to evaluate the efficacy of Valproic Acid (VPA) to both slow the progression of visual function loss and/or to restore visual function in patients with Autosomal Dominant Retinitis Pigmentosa (RP)…
- Trial name
- VPA (NCT01233609)
- Testing
- Valproic Acid
- Where
- 6 sites in United States
- Volunteers
- 90 people
- Sponsor
- Foundation Fighting Blindness
Glaucoma, Open-Angle
Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
To evaluate the efficacy of citicoline eye drops 2% in reducing visual field deterioration in patients with progressing OAG treated according to best clinical practice.
- Trial name
- NCT05710198
- Testing
- Citicoline eye drops 2%
- Where
- Italy
- Volunteers
- 1,000 people
- Sponsor
- Omikron Italia S.r.l.
Visual Fields Hemianopsia, Hemianopsia, Homonymous
Visual Perceptual Learning for the Treatment of Visual Field Defect
This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain damage.
- Trial name
- VIVID2 (NCT04102605)
- Testing
- Nunap Vision, Nunap Vision-C
- Where
- 5 sites in South Korea
- Volunteers
- 80 people
- Sponsor
- Nunaps Inc
Carpal Tunnel Syndrome
Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome
The purpose of the study is to determine the effectiveness of the treatment with very low frequency magnetic fields (ELF) on the reduction of pain and the relief of the associated signs such as sensitivity disorders that affect…
- Trial name
- NCT02891512
- Testing
- ELF, Xinepa®
- Where
- Italy
- Volunteers
- 31 people
- Sponsor
- University of Roma La Sapienza
Age Related Macular Degeneration
Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects
The FORESEE HOME is used in the recent years to detect Age-related Macular Degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes including choroidal…
- Trial name
- NCT00884637
- Where
- Israel
- Volunteers
- 15 people
- Sponsor
- Notal Vision Ltd.
Primary Open-Angle Glaucoma (POAG)
Effect of Niacinamide Supplementation in Glaucoma
Niacinamide is a chemical derivative of niacin, also known as vitamin B3. Through its complex role in the energetic metabolism, it has been evaluated and proven useful in several neurodegenerative disorders, such as Alzheimer's…
- Trial name
- NiSPoG (NCT07007260)
- Testing
- niacinamide supplementation
- Where
- Romania
- Volunteers
- 58 people
- Sponsor
- University of Medicine and Pharmacy Craiova
Lenses, Intraocular, Visual Fields
Visual Field Changes in TECNIS ZCB00 Monofocal vs. TECNIS Symfony Extended Depth of Focus Intraocular Lens Implantation
Glaucoma is a leading cause of blindness worldwide. Damage to the optic nerve results in vision loss gradually. This vision loss can be detected by using visual field testing, and is a way of monitoring glaucoma progression.
- Conditions
- Lenses, Intraocular, Visual Fields, Cataract
- Trial name
- NCT03505827
- Testing
- 24-2 SITA Standard Humphrey Visual Field Test
- Where
- 2 sites in Canada
- Sponsor
- Western University, Canada
Retinitis Pigmentosa (RP), Extensive Macular Atrophy With Pseudodrusen (EMAP)
Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases
This prospective, comparative pilot study investigates the safety and functional outcomes of intravitreal adalimumab (ADA) in patients with Retinitis Pigmentosa (RP) and Extensive Macular Atrophy with Pseudodrusen-like Appearance…
- Trial name
- ADARET (NCT07348588)
- Testing
- Intravitreal Adalimumab
- Where
- Brazil
- Volunteers
- 30 people
- Sponsor
- Centro de Pesquisa Rubens Siqueira
Vision Disorders, Stress, Psychological
Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa
The aim of this study is to evaluate the efficacy of cognitive - behavioral therapy for the control of psychopathological stress and the disease of people with Retinitis Pigmentosa (RP).
- Conditions
- Vision Disorders, Stress, Psychological, Psychopathy, Self Efficacy
- Trial name
- RCT (NCT03368027)
- Testing
- A cognitive-behavioral intervention program, Standard intervention
- Where
- Spain
- Volunteers
- 30 people
- Sponsor
- Universidad de Granada
Retinitis Pigmentosa Syndrome
Evaluation of the Visual Field on the Ground
Retinopathy pigmentosa (which affects about 40,000 patients in France) leads to destruction of the peripheral retina. This condition, often familial, frequently affects young patients.
- Trial name
- ECVS (NCT03989622)
- Testing
- evaluation of the visual field on the ground
- Sponsor
- University Hospital, Limoges
Visual Fields Hemianopsia, Hemianopsia, Homonymous
Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke
This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain.
- Trial name
- NCT05525949
- Testing
- VIVID Brain, No-treatment Control
- Where
- 12 sites in South Korea
- Volunteers
- 93 people
- Sponsor
- Nunaps Inc
Visual Field Defects
Virtual Reality-based Perceptual Learning Therapy for Visually Impaired Population
Visual impairments significantly impact individuals' activities of daily living (ADL) and quality of life (QoL). While perceptual learning (PL) has shown promise in vision rehabilitation, traditional PL usually involves a…
- Trial name
- NCT07809243
- Testing
- Virtual Reality-based Perceptual Learning Training
- Where
- Hong Kong
- Volunteers
- 20 people
- Sponsor
- Centre for Eye and Vision Research
Open Angle Glaucoma, Eye Diseases
Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma
The purpose of this study is to investigate the effect of repeated low-level red-light therapy on existing visual field damages in primary open-angle glaucoma patients.
- Trial name
- NCT05309811
- Testing
- RLRL therapy, Routine IOP-lowering medications
- Where
- China
- Volunteers
- 44 people
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
Retinitis Pigmentosa, AMD
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the fundus of the patient and present stimuli in specific anatomically-defined locations.
- Trial name
- NCT03322930
- Testing
- Rod sensitivity
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Retina Foundation of the Southwest
Acute Stroke, Visual Field Loss
Fluoxetine for Visual Recovery After Ischemic Stroke
The purpose of this study is to determine whether fluoxetine, a selective serotonin reuptake inhibitor commonly used for depression, enhances visual recovery after an acute ischemic stroke.
- Trial name
- FLUORESCE (NCT02737930)
- Testing
- Fluoxetine
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Bogachan Sahin